AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Fallopian Tube Carcinoma

Open on HERB 2.0 ↗
17
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00096200
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Completed · Phase 2
NCT00352300
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
Completed · Phase 1
NCT00499252
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Fallopian Tube Carcinoma
🏥 Names
Disease Name
Fallopian Tube Carcinoma
Alias Names
Fallopian Tube Cancer; Fallopian Tube Neoplasms; Fallopian Tube Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms
HPO Class
Neoplasm; Abnormality of the genitourinary system
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
HERB DB
HBDIS005123 ↗
MeSH
D005185 ↗
HPO
HP:0030394 ↗
Disease Ontology
1963; 1964
DisGeNET
C0238122
🔍 Raw view — every non-empty column on this row (29 fields)
name
Fallopian Tube Carcinoma
alias name
Fallopian Tube Cancer; Fallopian Tube Neoplasms; Fallopian Tube Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms
hpo disease class
Neoplasm; Abnormality of the genitourinary system
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C13
hpo disease class id
HP:0000119; HP:0002664
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS005123
disgenet id
C0238122
mesh id
D005185
hpo id
HP:0030394
do id
1963; 1964

⚗️ Related Ingredients

1 · shared evidence
Taxol

📋 Clinical Trials

12 · subject of clinical study
NCT00096200 Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With R
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
NCT00352300 Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III o
→ Fallopian Tube Carcinoma|Infectious Disorder|Neutr
NCT00499252 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With
→ Fallopian Tube Carcinoma|Primary Peritoneal Carcin
NCT00814086 Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage I
→ Chemotherapeutic Agent Toxicity|Endometrial Adenoc
NCT00954174 Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnos
→ Mixed Mesodermal (Mullerian) Tumor|Ovarian Carcino
NCT00989651 Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Ne
→ Fallopian Tube Carcinoma|Fallopian Tube Carcinosar
NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevac
→ Borderline Ovarian Mucinous Tumor|Ovarian Mucinous
NCT01097746 First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Par
→ Fallopian Tube Carcinoma|Fallopian Tube Clear Cell
NCT01199263 Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
NCT01294293 TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Pacli
→ Malignant Ovarian Mixed Epithelial Tumor|Ovarian B
NCT01468909 Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Per
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
NCT01716715 Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epi
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables